May 15, 2018 / 1:29 PM / 4 months ago

BRIEF-Therapeutic Solutions To Initiate Clinical Trial Of Cancer Immunotherapy Adjuvant Nanostilbene

May 15 (Reuters) - Therapeutic Solutions International Inc :

* THERAPEUTIC SOLUTIONS INTERNATIONAL, INC., TO INITIATE CLINICAL TRIAL OF PATENTED CANCER IMMUNOTHERAPY ADJUVANT NANOSTILBENE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below